Geftibenz 250mg Tablet

Product Introduction

Geftibenz 250mg Tablet is a pharmaceutical medication used primarily for the treatment of non-small cell lung cancer (NSCLC). It belongs to a class of drugs known as tyrosine kinase inhibitors, specifically targeting the epidermal growth factor receptor (EGFR). Geftibenz is the brand name, and the active pharmaceutical ingredient is gefitinib, which is designed to block the activity of a naturally occurring substance that may be involved in cancer cell growth and survival.

This medication is manufactured in the form of 250mg tablets, which are intended for oral administration. As an EGFR inhibitor, Geftibenz is particularly effective against cancers that exhibit certain types of EGFR mutations. It is typically prescribed after other cancer medicines have been tried without success.

Uses of Geftibenz 250mg Tablet

The primary indication for Geftibenz 250mg Tablet is the treatment of non-small cell lung cancer. This includes its use in patients who have specific types of EGFR mutations, which are identified through genetic testing. The presence of these mutations can significantly increase the efficacy of gefitinib as a treatment option.

Geftibenz is often used in cases where the cancer has metastasized, meaning it has spread from the lungs to other parts of the body. Its use is generally considered when the cancer is advanced and has not responded adequately to conventional chemotherapy and other treatments.

Benefits of Geftibenz 250mg Tablet

Geftibenz 250mg Tablet offers several benefits for patients with NSCLC who have specific EGFR mutations. Its targeted therapy approach allows for more precision in treating cancer, focusing on abnormal signaling pathways that lead to tumor growth and survival. Here are some key benefits:

1. Improved Survival Rates: Clinical trials have shown that patients with EGFR mutation-positive NSCLC may experience an improvement in survival rates when treated with Geftibenz, compared to traditional chemotherapy.
2. Reduced Side Effects: Because it specifically targets cancer cells with less impact on normal cells, gefitinib often results in fewer and less severe side effects compared to traditional chemotherapy. This can significantly improve the quality of life for patients undergoing cancer treatment.
3. Oral Administration: Geftibenz is taken orally, which is more convenient and generally preferred by patients over intravenous chemotherapy. This can make treatment less disruptive to a patient’s daily life and decrease the need for frequent hospital visits.
4. Effective for Resistant Cancer: For patients whose cancer has not responded to other treatments, Geftibenz offers a valuable alternative that can still be effective, particularly in genetically appropriate cases.

Side Effects of Geftibenz 250mg Tablet

Like all medications, Geftibenz 250mg Tablet can cause side effects, although not everyone experiences them. Common side effects associated with gefitinib include:

• Diarrhea: This is the most commonly reported side effect but can usually be managed with medication and dietary adjustments.
• Skin Problems: Some patients may develop rash, dry skin, or itching, which are generally manageable with skin care advice and topical treatments.
• Appetite Loss: Patients might experience reduced appetite which can lead to weight loss. Nutritional support and dietary changes can help mitigate this issue.
• Nausea and Vomiting: These are less common but can usually be controlled with anti-nausea medications.